Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease
Low-dose terlipressin treatment could considerably increase intestinal paralysis remission in ESLD patients with intestinal paralysis, and have good safety.
Authors
- Yu Lei (ORCID: https://orcid.org/0000-0002-0011-1515)
- Hu Li (ORCID: https://orcid.org/0000-0002-7917-7807)
- Shan Zhong (ORCID: https://orcid.org/0000-0003-3277-9226)
- Zhi Zhou
- Xiao Fu
- Hua Xu
- Huan Deng (ORCID: https://orcid.org/0000-0002-1596-2013)
- Xia Wan (ORCID: https://orcid.org/0009-0004-2612-0817)
Institutions
- Chongqing University (CN)
- Jiangjin Central Hospital (CN)
- First People's Hospital of Chongqing (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1186/s12876-025-03910-2
- Citations
- 1
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- Chongqing Medical University